Current Problems in Surgery: Gastric Cancer

Current Problems in Surgery

Volumn 43, Issue 8-9, 2006, Pages 566-670

  Clark, Clancy J ^a   Thirlby, Richard C ^a   Picozzi Jr , Vicent ^a   Schembre, Drew B ^a   Cummings, Felicia P ^a   Lin, Eugene ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; BRCA2 PROTEIN; CALCIUM; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; CISPLATIN; COMPLEMENTARY DNA; CYANOCOBALAMIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLAVONOID; FLUOROURACIL; FOLIC ACID; IRINOTECAN; IRON; METHOTREXATE; MITOMYCIN C; NITRATE; OXALIPLATIN; PACLITAXEL; SELENIUM; SODIUM CHLORIDE; UNINDEXED DRUG; VASCULOTROPIN; VITAMIN D;

ADENOMATOUS POLYP; ALCOHOL CONSUMPTION; ANOREXIA; ARTICLE; BARIUM ENEMA; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHOLECYSTECTOMY; CIGARETTE SMOKING; CLINICAL FEATURE; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DEHYDRATION; DIARRHEA; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DNA MICROARRAY; EATING HABIT; ENDOSCOPIC ECHOGRAPHY; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; FAMILY HISTORY; FATIGUE; FEEDING BEHAVIOR; FOOD COMPOSITION; FOOD PRESERVATION; FOOD QUALITY; FREEZING; FRUIT; GALLSTONE; GASTRECTOMY; GENE MUTATION; GENETIC POLYMORPHISM; HAND FOOT SYNDROME; HEART DISEASE; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; JEJUNOSTOMY; KIDNEY DYSFUNCTION; LAPAROSCOPIC SURGERY; LAPAROSCOPY; LIVER DYSFUNCTION; LUNG CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MENETRIER DISEASE; MICROSATELLITE INSTABILITY; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; MUSCULOSKELETAL PAIN; NAUSEA AND VOMITING; NEUTROPENIA; NOSE FEEDING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL HEALTH; OSTEOMALACIA; PARANEOPLASTIC SYNDROME; PARTIAL GASTRECTOMY; PATHOPHYSIOLOGY; PATIENT COUNSELING; PEPTIC ULCER; PERIPHERAL NEUROPATHY; PERNICIOUS ANEMIA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; RISK FACTOR; ROUX Y ANASTOMOSIS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SERIAL ANALYSIS OF GENE EXPRESSION; SOCIAL STATUS; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STEATORRHEA; STOMACH BIOPSY; STOMACH CANCER; STOMACH PERFORATION; STOMACH POLYPOSIS; STOMACH STUMP CARCINOMA; SUBTRACTIVE HYBRIDIZATION; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; TOTAL STOMACH RESECTION; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING; VEGETABLE; WEIGHT REDUCTION;

EID: 33748874887     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2006.06.003     Document Type: Note

References (282)

1. Ferlay J., Bray F., Pisani P., and Parkin D.M. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide (2004), IARC Press, Lyon
2. Parkin D.M., Whelan S.L., Ferlay J., and Storm H. Cancer Incidence in Five Continents, Vol. I to VIII (2005), IARC Press, Lyon
3. Corella D., and Guillen M. Dietary habits and epidemiology of gastric carcinoma. Hepatogastroenterology 48 (2001) 1537-1543
4. Ries L., Eisner M., Kosary C., Hankey B., Miller B., Clegg L., Mariotto A., Feuer E., and Edwards B. SEER Cancer Statistics Review (1975-2002)
5. Tsugane S., de Souza J.M., Costa Jr. M.L., Mirra A.P., Gotlieb S.L., Laurenti R., et al. Cancer incidence rates among Japanese immigrants in the city of Sao Paulo, Brazil, 1969-78. Cancer Causes Control 1 (1990) 189-193
6. Stemmermann G.N. Gastric cancer in the Hawaii. Japanese Gann 68 (1977) 525-535
7. Coggon D., Barker D.J., Cole R.B., and Nelson M. Stomach cancer and food storage. J Natl Cancer Inst 81 (1989) 1178-1182
8. Boeing H., Frentzel-Beyme R., Berger M., Berndt V., Gores W., et al. Case-control study on stomach cancer in Germany. Int J Cancer 47 (1991) 858-864
9. Munoz N., Plummer M., Vivas J., Moreno V., De S.S., Lopez G., et al. A case-control study of gastric cancer in Venezuela. Int J Cancer 93 (2001) 417-423
10. Jedrychowski W., Boeing H., Popiela T., Wahrendorf J., Tobiasz-Adamczyk B., and Kulig J. Dietary practices in households as risk factors for stomach cancer: a familial study in Poland. Eur J Cancer Prev 1 (1992) 297-304
11. van den Brandt P.A., Botterweck A.A., and Goldbohm R.A. Salt intake, cured meat consumption, refrigerator use and stomach cancer incidence: a prospective cohort study (Netherlands). Cancer Causes Control 14 (2003) 427-438
12. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
13. Locke III G.R., Talley N.J., Carpenter H.A., Harmsen W.S., Zinsmeister A.R., and Melton III L.J. Changes in the site- and histology-specific incidence of gastric cancer during a 50-year period. Gastroenterology 109 (1995) 1750-1756
14. Shang J., and Pena A.S. Multidisciplinary approach to understand the pathogenesis of gastric cancer. World J Gastroenterol 11 (2005) 4131-4139
15. Kubo A., and Corley D.A. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 99 (2004) 582-588
16. Blot W.J., Devesa S.S., Kneller R.W., and Fraumeni Jr. J.F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265 (1991) 1287-1289
17. Wang W.H., Huang J.Q., Zheng G.F., Lam S.K., Karlberg J., and Wong B.C. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst 95 (2003) 1784-1791
18. Correa P., Piazuelo M.B., and Camargo M.C. The future of gastric cancer prevention. Gastric Cancer 7 (2004) 9-16
19. Watson P., and Lynch H.T. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71 (1993) 677-685
20. Aarnio M., Salovaara R., Aaltonen L.A., Mecklin J.P., and Jarvinen H.J. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer 74 (1997) 551-555
21. Theuer C.P., Campbell B.S., Peel D.J., Lin F., Carpenter P., Ziogas A., et al. Microsatellite instability in Japanese vs European American patients with gastric cancer. Arch Surg 137 (2002) 960-965
22. Caldas C., Carneiro F., Lynch H.T., Yokota J., Wiesner G.L., Powell S.M., et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 36 (1999) 873-880
23. Guilford P., Hopkins J., Harraway J., McLeod M., McLeod N., Harawira P., et al. E-cadherin germline mutations in familial gastric cancer. Nature 392 6674 (1998) 402-405
24. Becker K.F., Atkinson M.J., Reich U., Becker I., Nekarda H., Siewert J.R., et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54 (1994) 3845-3852
25. Tahara E. Mechanisms of carcinogenesis: contributions of molecular epidemiology. In: Buffler P.A. (Ed). Mechanisms of Carcinogenesis: Contributions of Molecular Epidemiology (2004), International Agency for Research on Cancer, Lyon 327-349
26. World Health Organization. Diet, Nutrition, and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Expert Consultation (2003), World Health Organization, Geneva
27. Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 96 (2005) 1-6
28. Sugimura T., and Fujimura S. Tumour production in glandular stomach of rat by N-methyl-N′-nitro-N-nitrosoguanidine. Nature 216 118 (1967) 943-944
29. Yamaguchi N., and Kakizoe T. Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer. Lancet Oncol 2 (2001) 88-94
30. Blot W.J., Li J.Y., Taylor P.R., Guo W., Dawsey S., Wang G.Q., et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85 (1993) 1483-1492
31. Albanes D., Heinonen O.P., Taylor P.R., Virtamo J., Edwards B.K., Rautalahti M., et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 88 (1996) 1560-1570
32. Virtamo J., Pietinen P., Huttunen J.K., Korhonen P., Malila N., Virtanen M.J., et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 290 (2003) 476-485
33. Tredaniel J., Boffetta P., Buiatti E., Saracci R., and Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer 72 (1997) 565-573
34. Gammon M.D., Schoenberg J.B., Ahsan H., Risch H.A., Vaughan T.L., Chow W.H., et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 89 (1997) 1277-1284
35. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, and National Cancer Institute (U.S.). Alcohol Drinking (1988), World Health Organization, International Agency for Research on Cancer, Lyon, France
36. World Cancer RF, and American Institute for Cancer Research. Food, Nutrition, and the Prevention of Cancer: A Global Perspective (1997), The Institute, Washington, DC
37. Warren J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1 (1983) 1273-1275
38. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61 (1994) 1-241
39. Huang J.Q., Sridhar S., Chen Y., and Hunt R.H. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114 (1998) 1169-1179
40. Holcombe C. Helicobacter pylori: the African enigma. Gut 33 (1992) 429-431
41. Marshall B.J., and Windsor H.M. The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention. Med Clin North Am 89 (2005) 313-344 viii
42. Malaty H.M., and Graham D.Y. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut 35 (1994) 742-745
43. Staat M.A., Kruszon-Moran D., McQuillan G.M., and Kaslow R.A. A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States. J Infect Dis 174 (1996) 1120-1123
44. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 6776 (2000) 398-402
45. Zagari R.M., and Bazzoli F. Gastric cancer: who is at risk?. Dig Dis 22 (2004) 302-305
46. Sugiyama A., Maruta F., Ikeno T., Ishida K., Kawasaki S., Katsuyama T., et al. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 58 (1998) 2067-2069
47. Nomura A., Stemmermann G.N., Chyou P.H., Kato I., Perez-Perez G.I., and Blaser M.J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325 (1991) 1132-1136
48. Parsonnet J., Friedman G.D., Vandersteen D.P., Chang Y., Vogelman J.H., Orentreich N., et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325 (1991) 1127-1131
49. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 341 (1993) 1359-1362
50. Uemura N., Mukai T., Okamoto S., Yamaguchi S., Mashiba H., Taniyama K., et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 6 (1997) 639-642
51. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345 (2001) 784-789
52. Ebert M.P., Leodolter A., and Malfertheiner P. Novel strategies in the prevention of gastric cancer. Hepatogastroenterology 48 42 (2001) 1569-1571
53. Wong B.C., Lam S.K., Wong W.M., Chen J.S., Zheng T.T., Feng R.E., et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291 (2004) 187-194
54. Malfertheiner P., Sipponen P., Naumann M., Moayyedi P., Megraud F., Xiao S.D., et al. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol 100 (2005) 2100-2115
55. Aranha G.V., and Georgen R. Gastric linitis plastica is not a surgical disease. Surgery 106 (1989) 758-762
56. Gertsch P., Yip S.K., Chow L.W., and Lauder I.J. Free perforation of gastric carcinoma. Results of surgical treatment. Arch Surg 130 (1995) 177-181
57. Allum W.H., Brearley S., Wheatley K.E., Dykes P.W., and Keighley M.R. Acute haemorrhage from gastric malignancy. Br J Surg 77 (1990) 19-20
58. Inoue M., and Tsugane S. Epidemiology of gastric cancer in Japan. Postgrad Med J 81 957 (2005) 419-424
59. Maruyama M., Barreto-Zuniga R., and Kimura K. Misconceptions on early gastric cancer in Japan. Hepatogastroenterology 48 42 (2001) 1560-1564
60. Stael von H.C., Eriksson S., Huldt B., and Hammar E. Endoscopic screening during 17 years for gastric stump carcinoma. A prospective clinical trial. Scand J Gastroenterol 26 (1991) 1020-1026
61. Everett S.M., and Axon A.T. Early gastric cancer: disease or pseudo-disease?. Lancet 351 (1998) 1350-1352
62. Wobbes T., Thomas C.M., Segers M.F., and Nagengast F.M. Evaluation of seven tumor markers (CA 50, CA 19-9, CA 19-9 TruQuant, CA 72-4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma. Cancer 69 (1992) 2036-2041
63. Chan A.O., Chu K.M., Lam S.K., Cheung K.L., Law S., Kwok K.F., et al. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin. Cancer 104 (2005) 740-746
64. Karayiannakis A.J., Syrigos K.N., Polychronidis A., Zbar A., Kouraklis G., Simopoulos C., et al. Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery. Ann Surg 236 (2002) 37-42
65. Chen J., Rocken C., Malfertheiner P., and Ebert M.P. Recent advances in molecular diagnosis and therapy of gastric cancer. Dig Dis 22 (2004) 380-385
66. Tay S.T., Leong S.H., Yu K., Aggarwal A., Tan S.Y., Lee C.H., et al. A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes. Cancer Res 63 (2003) 3309-3316
67. Yasui W., Oue N., Ito R., Kuraoka K., and Nakayama H. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci 95 (2004) 385-392
68. Tomlinson A.J., Hincapie M., Morris G.E., and Chicz R.M. Global proteome analysis of a human gastric carcinoma. Electrophoresis 23 (2002) 3233-3240
69. Halvorsen Jr. R.A., Yee J., and McCormick V.D. Diagnosis and staging of gastric cancer. Semin Oncol 23 (1996) 325-335
70. Low V.H., Levine M.S., Rubesin S.E., Laufer I., and Herlinger H. Diagnosis of gastric carcinoma: sensitivity of double-contrast barium studies. AJR Am J Roentgenol 162 (1994) 329-334
71. Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery. Jpn J Surg 3 (1973) 61-71
72. Fuchs C.S., and Mayer R.J. Gastric carcinoma. N Engl J Med 333 (1995) 32-41
73. Gore R.M., and Levine M.S. Textbook of gastrointestinal surgery. 2nd ed. (2000), WB Saunders, Philadelphia
74. Levine M.S., Creteur V., Kressel H.Y., Laufer I., and Herlinger H. Benign gastric ulcers: diagnosis and follow-up with double-contrast radiography. Radiology 164 (1987) 9-13
75. Thompson G., Somers S., and Stevenson G.W. Benign gastric ulcer: a reliable radiologic diagnosis?. AJR Am J Roentgenol 141 (1983) 331-333
76. Shindoh N., Nakagawa T., Ozaki Y., Kyogoku S., Sumi Y., and Katayama H. Overlooked gastric carcinoma: pitfalls in upper gastrointestinal radiology. Radiology 217 (2000) 409-414
77. Japanese classification of gastric carcinoma. 2nd English edition. Response assessment of chemotherapy and radiotherapy for gastric carcinoma: clinical criteria. Gastric Cancer 4 (2001) 1-8
78. Ming S.C. Gastric carcinoma. A pathobiological classification. Cancer 39 (1977) 2475-2485
79. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64 (1965) 31-49
80. Cunningham S.C., Kamangar F., Kim M.P., Hammoud S., Haque R., Maitra A., et al. Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg 9 (2005) 718-725
81. Wu M.S., Shun C.T., Wang H.P., Sheu J.C., Lee W.J., Wang T.H., et al. Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology 112 (1997) 1457-1465
82. Kokkola A., and Sipponen P. Gastric carcinoma in young adults. Hepatogastroenterology 48 (2001) 1552-1555
83. Hansson L.E., Sparen P., and Nyren O. Survival in stomach cancer is improving: results of a nationwide population-based Swedish study. Ann Surg 230 (1999) 162-169
84. Buzzoni R., Bajetta E., Di B.M., Miceli R., Beretta E., Ferrario E., et al. Pathological features as predictors of recurrence after radical resection of gastric cancer. Br J Surg 93 (2005) 205-209
85. Roder J.D., Bottcher K., Busch R., Wittekind C., Hermanek P., Siewert J.R., and German Gastric Cancer Study Group. Classification of regional lymph node metastasis from gastric carcinoma. Cancer 82 (1998) 621-631
86. Siewert J.R., Bottcher K., Stein H.J., and Roder J.D. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228 (1998) 449-461
87. Schott A., Vogel I., Krueger U., Kalthoff H., Schreiber H.W., Schmiegel W., et al. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 227 (1998) 372-379
88. Kodera Y., Nakanishi H., Ito S., Mochizuki Y., Ohashi N., Yamamura Y., et al. Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: analysis of real time reverse transcriptase-polymerase chain reaction after 5 years of followup. J Am Coll Surg 202 (2006) 231-236
89. Jonas S., Weinrich M., Tullius S.G., Al-Abadi H., Steinbrich R., Radke C., et al. Microscopic tumor cell dissemination in gastric cancer. Surg Today 34 (2004) 101-106
90. Yasuda K., Adachi Y., Shiraishi N., Inomata M., Takeuchi H., and Kitano S. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol 9 (2002) 771-774
91. Siewert J.R., Feith M., Werner M., and Stein H.J. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 232 (2000) 353-361
92. Hundahl S.A., Macdonald J.S., Benedetti J., and Fitzsimmons T. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 9 (2002) 278-286
93. Marrelli D., Roviello F., De S.A., Fotia G., Giliberto C., Garosi L., and Pinto E. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection. J Am Coll Surg 198 (2004) 51-58
94. Kim S.H., Karpeh M.S., Klimstra D.S., Leung D., and Brennan M.F. Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg 3 (1999) 24-33
95. Novotny A.R., Schuhmacher C., Busch R., Kattan M.W., Brennan M.F., and Siewert J.R. Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe. Ann Surg 243 (2006) 74-81
96. Dicken B.J., Graham K., Hamilton S.M., Andrews S., Lai R., Listgarten J., et al. Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques. Ann Surg 243 (2006) 64-73
97. Marrelli D., DeStefano A., deManzoni G., Morgagni P., DiLeo A., and Roviello F. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg 241 (2005) 247-255
98. Roesch T. Endoscopic ultrasonography: equipment and technique. Gastrointest Endosc Clin N Am 15 (2005) 13-31 vii
99. Paramo J.C., and Gomez G. Dynamic CT in the preoperative evaluation of patients with gastric cancer: correlation with surgical findings and pathology. Ann Surg Oncol 6 (1999) 379-384
100. Davies J., Chalmers A.G., Sue-Ling H.M., May J., Miller G.V., Martin I.G., et al. Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging. Gut 41 (1997) 314-319
101. Willis S., Truong S., Gribnitz S., Fass J., and Schumpelick V. Endoscopic ultrasonography in the preoperative staging of gastric cancer: accuracy and impact on surgical therapy. Surg Endosc 14 (2000) 951-954
102. Kelly S., Harris K.M., Berry E., Hutton J., Roderick P., Cullingworth J., et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 49 (2001) 534-539
103. Bhandari S., Shim C.S., Kim J.H., Jung I.S., Cho J.Y., Lee J.S., et al. Usefulness of three-dimensional, multidetector row CT (virtual gastroscopy and multiplanar reconstruction) in the evaluation of gastric cancer: a comparison with conventional endoscopy, EUS, and histopathology. Gastrointest Endosc 59 (2004) 619-626
104. Aithal G.P., Anagnostopoulos G.K., and Kaye P. EUS-guided Trucut mural biopsies in the investigation of unexplained thickening of the esophagogastric wall. Gastrointest Endosc 62 (2005) 624-629
105. Nguyen P.T., and Chang K.J. EUS in the detection of ascites and EUS-guided paracentesis. Gastrointest Endosc 54 (2001) 336-339
106. Prasad P., Schmulewitz N., Patel A., Varadarajulu S., Wildi S.M., Roberts S., et al. Detection of occult liver metastases during EUS for staging of malignancies. Gastrointest Endosc 59 (2004) 49-53
107. Raju G.S., and Waxman I. High-frequency US probe sonography-assisted endoscopic mucosal resection. Gastrointest Endosc 52 6 Suppl (2000) S39-S49
108. Buskens C.J., Westerterp M., Lagarde S.M., Bergman J.J., ten Kate F.J., and van Lanschot J.J. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 60 (2004) 703-710
109. Marks W.M., Callen P.W., and Moss A.A. Gastroesophageal region: source of confusion on CT. AJR Am J Roentgenol 136 (1981) 359-362
110. Botet J.F., Lightdale C.J., Zauber A.G., Gerdes H., Winawer S.J., Urmacher C., et al. Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology 181 (1991) 426-432
111. Habermann C.R., Weiss F., Riecken R., Honarpisheh H., Bohnacker S., Staedtler C., et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 230 (2004) 465-471
112. Dux M., Richter G.M., Hansmann J., Kuntz C., and Kauffmann G.W. Helical hydro-CT for diagnosis and staging of gastric carcinoma. J Comput Assist Tomogr 23 (1999) 913-922
113. Fukuya T., Honda H., Kaneko K., Kuroiwa T., Yoshimitsu K., Irie H., et al. Efficacy of helical CT in T-staging of gastric cancer. J Comput Assist Tomogr 21 (1997) 73-81
114. Kumano S., Murakami T., Kim T., Hori M., Iannaccone R., Nakata S., et al. T staging of gastric cancer: role of multi-detector row CT. Radiology 237 (2005) 961-966
115. Lee J.H., Jeong Y.K., Kim D.H., Go B.K., Woo Y.J., Ham S.Y., and Yang S.O. Two-phase helical CT for detection of early gastric carcinoma: importance of the mucosal phase for analysis of the abnormal mucosal layer. J Comput Assist Tomogr 24 (2000) 777-782
116. Shimizu K., Ito K., Matsunaga N., Shimizu A., and Kawakami Y. Diagnosis of gastric cancer with mdct using the water-filling method and multiplanar reconstruction: CT-histologic correlation. AJR Am J Roentgenol 185 (2005) 1152-1158
117. Takao M., Fukuda T., Iwanaga S., Hayashi K., Kusano H., and Okudaira S. Gastric cancer: evaluation of triphasic spiral CT and radiologic-pathologic correlation. J Comput Assist Tomogr 22 (1998) 288-294
118. Minami M., Kawauchi N., Itai Y., Niki T., and Sasaki Y. Gastric tumors: radiologic-pathologic correlation and accuracy of T staging with dynamic CT. Radiology 185 (1992) 173-178
119. Tsuda K., Hori S., Murakami T., Nakamura H., Tomoda K., Nakanishi K., et al. Intramural invasion of gastric cancer: evaluation by CT with water-filling method. J Comput Assist Tomogr 19 (1995) 941-947
120. Fukuya T., Honda H., Hayashi T., Kaneko K., Tateshi Y., Ro T., et al. Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer. Radiology 197 (1995) 705-711
121. Kim A.Y., Han J.K., Seong C.K., Kim T.K., and Choi B.I. MRI in staging advanced gastric cancer: is it useful compared with spiral CT?. J Comput Assist Tomogr 24 (2000) 389-394
122. Sohn K.M., Lee J.M., Lee S.Y., Ahn B.Y., Park S.M., and Kim K.M. Comparing MR imaging and CT in the staging of gastric carcinoma. AJR Am J Roentgenol 174 (2000) 1551-1557
123. Antoch G., Saoudi N., Kuehl H., Dahmen G., Mueller S.P., Beyer T., et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22 1 (2004) 4357-4368
124. Chen J., Cheong J.H., Yun M.J., Kim J., Lim J.S., Hyung W.J., et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer 103 (2005) 2383-2390
125. Kim S.K., Kang K.W., Lee J.S., Kim H.K., Chang H.J., Choi J.Y., et al. Assessment of lymph node metastases using (18)F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 33 (2005) 148-155
126. Stahl A., Ott K., Weber W.A., Becker K., Link T., Siewert J.R., et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging 30 (2003) 288-295
127. Mochiki E., Kuwano H., Katoh H., Asao T., Oriuchi N., and Endo K. Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg 28 (2004) 247-253
128. Yoshioka T., Yamaguchi K., Kubota K., Saginoya T., Yamazaki T., Ido T., et al. Evaluation of 18F-FDG PET in patients with a metastatic, or recurrent, gastric cancer. J Nucl Med 44 (2003) 690-699
129. Yun M., Lim J.S., Noh S.H., Hyung W.J., Cheong J.H., Bong J.K., et al. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT. J Nucl Med 46 (2005) 1582-1588
130. De Potter T., Flamen P., Van C.E., Penninckx F., Filez L., Bormans G., et al. Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging 29 (2002) 525-529
131. Ott K., Fink U., Becker K., Stahl A., Dittler H.J., Busch R., et al. Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 21 (2003) 4604-4610
132. Shandall A., and Johnson C. Laparoscopy or scanning in oesophageal and gastric carcinoma?. Br J Surg 72 (1985) 449-451
133. Gross E., Bancewicz J., and Ingram G. Assessment of gastric cancer by laparoscopy. Br Med J (Clin Res Ed) 288 (1984) 1577 (letter)
134. Watt I., Stewart I., Anderson D., Bell G., and Anderson J.R. Laparoscopy, ultrasound and computed tomography in cancer of the oesophagus and gastric cardia: a prospective comparison for detecting intra-abdominal metastases. Br J Surg 76 (1989) 1036-1039
135. Tschmelitsch J., Weiser M.R., and Karpeh M.S. Modern staging in gastric cancer. Surg Oncol 9 (2000) 23-30
136. Molloy R.G., McCourtney J.S., and Anderson J.R. Laparoscopy in the management of patients with cancer of the gastric cardia and oesophagus. Br J Surg 82 (1995) 352-354
137. Kriplani A.K., and Kapur B.M. Laparoscopy for pre-operative staging and assessment of operability in gastric carcinoma. Gastrointest Endosc 37 (1991) 441-443
138. Burke E.C., Karpeh M.S., Conlon K.C., and Brennan M.F. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg 225 (1997) 262-267
139. Finch M.D., John T.G., Garden O.J., Allan P.L., and Paterson-Brown S. Laparoscopic ultrasonography for staging gastroesophageal cancer. Surgery 121 (1997) 10-17
140. Jaffer A, Bekaii-Saab T, Javie M, Minsky B. Gastric Cancer Clinical Practice Guidelines in Oncology. http://www.nccn.org/professionals/physician_gls/PDF/gastric.pdf, 2006, v.1.2006, accessed 8/22/2006
141. D'Ugo D.M., Pende V., Persiani R., Rausei S., and Picciocchi A. Laparoscopic staging of gastric cancer: an overview. J Am Coll Surg 196 (2003) 965-974
142. Inada T., Ogata Y., Kubota T., Ishihara M., Tomikawa M., Ando J., et al. D2-lymphadenectomy improves the survival of patients with peritoneal cytology-positive gastric cancer. Anticancer Res 22 (2002) 291-294
143. Scartozzi M., Galizia E., Graziano F., Catalano V., Berardi R., Baldelli A.M., et al. Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients. Br J Cancer 92 28 (2005) 1051-1054
144. Harrison L.E., Karpeh M.S., and Brennan M.F. Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J Gastrointest Surg 2 (1998) 126-131
145. Cuschieri A., Weeden S., Fielding J., Bancewicz J., Craven J., Joypaul V., et al., Surgical Co-operative Group. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer 79 9-10 (1999) 1522-1530
146. Bonenkamp J.J., Hermans J., Sasako M., van de Velde C.J., Welvaart K., Songun I., et al. Extended lymph-node dissection for gastric cancer. N Engl J Med 340 (1999) 908-914
147. Fatouros M., Roukos D.H., Lorenz M., Arampatzis I., Hottentrott C., Encke A., et al. Impact of spleen preservation in patients with gastric cancer. Anticancer Res 25 (2005) 3023-3030
148. Brady M.S., Rogatko A., Dent L.L., and Shiu M.H. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg 126 (1991) 359-364
149. Griffith J.P., Sue-Ling H.M., Martin I., Dixon M.F., McMahon M.J., Axon A.T., et al. Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut 36 (1995) 684-690
150. Smith J.W., Shiu M.H., Kelsey L., and Brennan M.F. Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg 126 (1991) 1469-1473
151. Edwards P., Blackshaw G.R., Lewis W.G., Barry J.D., Allison M.C., and Jones D.R. Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer 90 (2004) 1888-1892
152. McCulloch P., Nita M.E., Kazi H., and Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 4 (2004) CD001964
153. Jansen E.P., Boot H., Verheij M., and van de Velde C.J. Optimal locoregional treatment in gastric cancer. J Clin Oncol 23 (2005) 4509-4517
154. McCulloch P., Niita M.E., Kazi H., and Gama-Rodrigues J.J. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg 92 (2005) 5-13
155. Karpeh M.S., Leon L., Klimstra D., and Brennan M.F. Lymph node staging in gastric cancer: is location more important than number?. An analysis of 1,038 patients. Ann Surg 232 (2000) 362-371
156. Bozzetti F., Bonfanti G., Bufalino R., Menotti V., Persano S., Andreola S., et al. Adequacy of margins of resection in gastrectomy for cancer. Ann Surg 196 (1982) 685-690
157. Harrison L.E., Karpeh M.S., and Brennan M.F. Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach. Ann Surg 225 (1997) 678-683
158. Zinninger M.M. Extension of gastric cancer in the intramural lymphatics and its relation to gastrectomy. Am Surg 20 (1954) 920-927
159. Gouzi J.L., Huguier M., Fagniez P.L., Launois B., Flamant Y., Lacaine F., et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg 209 (1989) 162-166
160. Robertson C.S., Chung S.C., Woods S.D., Griffin S.M., Raimes S.A., Lau J.T., et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 220 (1994) 176-182
161. Bozzetti F., Marubini E., Bonfanti G., Miceli R., Piano C., Crose N., et al., The Italian Gastrointestinal Tumor Study Group. Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. Ann Surg 226 (1997) 613-620
162. Bozzetti F., Marubini E., Bonfanti G., Miceli R., Piano C., Gennari L., and Italian Gastrointestinal Tumor Study Group. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Ann Surg 230 (1999) 170-178
163. Walther B.S., Oscarson J.E., Graffner H.O., Vallgren S., and Evander A. Esophagojejunostomy with the EEA stapler. Surgery 99 (1986) 598-603
164. Wong J., Cheung H., Lui R., Fan Y.W., Smith A., and Siu K.F. Esophagogastric anastomosis performed with a stapler: the occurrence of leakage and stricture. Surgery 101 (1987) 408-415
165. Seufert R.M., Schmidt-Matthiesen A., and Beyer A. Total gastrectomy and oesophagojejunostomy-a prospective randomized trial of hand-sutured versus mechanically stapled anastomoses. Br J Surg 77 (1990) 50-52
166. Walther B., Lowenhielm P., Strand S.E., Stahlberg F., Uvelius B., Oscarson J., et al. Healing of esophagojejunal anastomoses after experimental total gastrectomy. A comparative study using manually sutured or stapled anastomoses. Ann Surg 203 (1986) 439-446
167. Herfarth C., Schlag P., and Buhl K. Surgical procedures for gastric substitution. World J Surg 11 (1987) 689-698
168. Nakane Y., Okumura S., Akehira K., Okamura S., Boku T., Okusa T., et al. Jejunal pouch reconstruction after total gastrectomy for cancer. A randomized controlled trial. Ann Surg 222 (1995) 27-35
169. Nozoe T., Anai H., and Sugimachi K. Usefulness of reconstruction with jejunal pouch in total gastrectomy for gastric cancer in early improvement of nutritional condition. Am J Surg 181 (2001) 274-278
170. Thiede A., Fuchs K.H., and Hamelman H. Pouch and Roux-en-Y reconstruction after gastrectomy. Arch Surg 122 (1987) 837-842
171. Legaspi A., and Irani H. Stapled transabdominal lower esophageal anastomosis without purse-string suture. Surg Gynecol Obstet 170 (1990) 156-158
172. Tejero C.E., Ratia G.T., Fernandez F.L., Tieso H.A., and Jorge S.E. Double-stapling technique for mechanical circular oesophagojejunal anastomosis after total gastrectomy. Br J Surg 81 (1994) 408-409
173. Rohde H., Gebbensleben B., Bauer P., Stutzer H., and Zieschang J. Has there been any improvement in the staging of gastric cancer?. Findings from the German Gastric Cancer TNM Study Group. Cancer 64 (1989) 2465-2481
174. Kobayashi A., Nakagohri T., Konishi M., Inoue K., Takahashi S., Itou M., et al. Aggressive surgical treatment for T4 gastric cancer. J Gastrointest Surg 8 (2004) 464-470
175. Martin R.C., Jaques D.P., Brennan M.F., and Karpeh M. Extended local resection for advanced gastric cancer: increased survival versus increased morbidity. Ann Surg 236 (2002) 159-165
176. Shchepotin I.B., Chorny V.A., Nauta R.J., Shabahang M., Buras R.R., and Evans S.R. Extended surgical resection in T4 gastric cancer. Am J Surg 175 (1998) 123-126
177. Kunisaki C., Akiyama H., Nomura M., Matsuda G., Otsuka Y., Ono H.A., et al. Surgical outcomes in patients with t4 gastric carcinoma. J Am Coll Surg 202 (2006) 223-230
178. Sandler R.S., Johnson M.D., and Holland K.L. Risk of stomach cancer after gastric surgery for benign conditions. A case-control study. Dig Dis Sci 29 (1984) 703-708
179. Nelson R., Edwards S., and Tse B. Prophylactic nasogastric decompression after abdominal surgery. Cochrane Database Syst Rev 1 (2005) CD004929
180. Doglietto G.B., Papa V., Tortorelli A.P., Bossola M., Covino M., and Pacelli F. Nasojejunal tube placement after total gastrectomy: a multicenter prospective randomized trial. Arch Surg 139 (2004) 1309-1313
181. Watters J.M., Kirkpatrick S.M., Norris S.B., Shamji F.M., and Wells G.A. Immediate postoperative enteral feeding results in impaired respiratory mechanics and decreased mobility. Ann Surg 226 (1997) 369-377
182. McCarter M.D., Gomez M.E., and Daly J.M. Early postoperative enteral feeding following major upper gastrointestinal surgery. J Gastrointest Surg 1 (1997) 278-285
183. Gianotti L., Braga M., Vignali A., Balzano G., Zerbi A., Bisagni P., et al. Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms. Arch Surg 132 (1997) 1222-1229
184. Senkal M., Zumtobel V., Bauer K.H., Marpe B., Wolfram G., Frei A., et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 134 (1999) 1309-1316
185. Heys S.D., Walker L.G., Smith I., and Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 229 (1999) 467-477
186. Kobayashi T., Hisanaga M., Kanehiro H., Yamada Y., Ko S., and Nakajima Y. Analysis of risk factors for the development of gallstones after gastrectomy. Br J Surg 92 (2005) 1399-1403
187. Kim J., Lee J., Hyung W.J., Cheong J.H., Chen J., Choi S.H., et al. Gastric cancer surgery without drains: a prospective randomized trial. J Gastrointest Surg 8 (2004) 727-732
188. Allum W.H., Powell D.J., McConkey C.C., and Fielding J.W. Gastric cancer: a 25-year review. Br J Surg 76 (1989) 535-540
189. McCulloch P., Ward J., and Tekkis P.P. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ 327 22 (2003) 1192-1197
190. Park D.J., Lee H.J., Kim H.H., Yang H.K., Lee K.U., and Choe K.J. Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg 92 (2005) 1099-1102
191. Shchepotin I.B., Evans S.R., Chorny V.A., Shabahang M., Buras R.R., and Nauta R.J. Postoperative complications requiring relaparotomies after 700 gastrectomies performed for gastric cancer. Am J Surg 171 (1996) 270-273
192. Sasako M., Katai H., Sano T., and Maruyama K. Management of complications after gastrectomy with extended lymphadenectomy. Surg Oncol 9 (2000) 31-34
193. Lang H., Piso P., Stukenborg C., Raab R., and Jahne J. Management and results of proximal anastomotic leaks in a series of 1114 total gastrectomies for gastric carcinoma. Eur J Surg Oncol 26 (2000) 168-171
194. Langer F.B., Wenzl E., Prager G., Salat A., Miholic J., Mang T., et al. Management of postoperative esophageal leaks with the Polyflex self-expanding covered plastic stent. Ann Thorac Surg 79 (2005) 398-403
195. Kwak H.S., Lee J.M., Jin G.Y., Han Y.M., and Yang D.H. Treatment of gastrojejunal anastomotic leak with a covered metallic stent. Hepatogastroenterology 50 (2003) 62-64
196. Woods S.C., and Seeley R.J. Understanding the physiology of obesity: review of recent developments in obesity research. Int J Obes Relat Metab Disord 26 Suppl 4 (2002) S8-S10
197. Chagnon Y.C., Perusse L., Weisnagel S.J., Rankinen T., and Bouchard C. The human obesity gene map: the 1999 update. Obes Res 8 (2000) 89-117
198. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346 (2002) 1623-1630
199. Miholic J., Meyer H.J., Kotzerke J., Balks J., Aebert H., Jahne J., et al. Emptying of the gastric substitute after total gastrectomy. Jejunal interposition versus Roux-y esophagojejunostomy. Ann Surg 210 (1989) 165-172
200. Kiyama T., Mizutani T., Okuda T., Fujita I., Tokunaga A., Tajiri T., et al. Postoperative changes in body composition after gastrectomy. J Gastrointest Surg 9 (2005) 313-319
201. Friess H., Bohm J., Muller M.W., Glasbrenner B., Riepl R.L., Malfertheiner P., et al. Maldigestion after total gastrectomy is associated with pancreatic insufficiency. Am J Gastroenterol 91 (1996) 341-347
202. Meyer J.H. Nutritional outcomes of gastric operations. In: Thirlby R.C. (Ed). Gastroenterology Clinics of North America (1994), WB Saunders, Philadelphia 227-260
203. Stael von Holstein C., Walther B., Ibrahimbegovic E., and Akesson B. Nutritional status after total and partial gastrectomy with Roux-en-Y reconstruction. Br J Surg 78 (1991) 1084-1087
204. Bisballe S., Eriksen E.F., Melsen F., Mosekilde L., Sorensen O.H., and Hessov I. Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry. Gut 32 (1991) 1303-1307
205. Inoue K., Shiomi K., Higashide S., Kan N., Nio Y., Tobe T., et al. Metabolic bone disease following gastrectomy: assessment by dual energy X-ray absorptiometry. Br J Surg 79 (1992) 321-324
206. Tovey F.I., Hall M.L., Ell P.J., and Hobsley M. Postgastrectomy osteoporosis. Br J Surg 78 (1991) 1335-1337
207. Wetscher G., Redmond E., Watfah C., Perdikis G., Gadenstatter M., and Pointner R. Bone disorders following total gastrectomy. Dig Dis Sci 39 (1994) 2511-2515
208. Kozawa K., Imawari M., Shimazu H., Kobori O., Osuga T., and Morioka Y. Vitamin D status after total gastrectomy. Dig Dis Sci 29 (1984) 411-416
209. Suzuki Y., Ishibashi Y., Omura N., Kawasaki N., Kashiwagi H., Yanaga K., et al. Alendronate improves vitamin D-resistant osteopenia triggered by gastrectomy in patients with gastric cancer followed long term. J Gastrointest Surg 9 (2005) 955-960
210. Northfield T.C., and Hall C.N. Carcinoma of the gastric stump: risks and pathogenesis. Gut 31 (1990) 1217-1219
211. Lundegardh G., Adami H.O., Helmick C., and Zack M. Risk of cancer following partial gastrectomy for benign ulcer disease. Br J Surg 81 (1994) 1164-1167
212. Mason G.R. Perspectives a century later on the "Ansa en Y" of Cesar Roux. Am J Surg 161 (1991) 262-265
213. Toftgaard C. Gastric cancer after peptic ulcer surgery. A historic prospective cohort investigation. Ann Surg 210 (1989) 159-164
214. Offerhaus G.J., Tersmette A.C., Huibregtse K., van de Stadt J., Tersmette K.W., Stijnen T., et al. Mortality caused by stomach cancer after remote partial gastrectomy for benign conditions: 40 years of follow up of an Amsterdam cohort of 2633 postgastrectomy patients. Gut 29 (1988) 1588-1590
215. Stael von Holstein C.C., Anderson H., Eriksson S.B., and Huldt B. Mortality after remote surgery for benign gastroduodenal disease. Gut 37 (1995) 617-622
216. Lundegardh G., Ekbom A., McLaughlin J.K., and Nyren O. Gastric cancer risk after vagotomy. Gut 35 (1994) 946-949
217. Schafer L.W., Larson D.E., Melton III L.J., Higgins J.A., and Ilstrup D.M. The risk of gastric carcinoma after surgical treatment for benign ulcer disease. A population-based study in Olmsted County, Minnesota. N Engl J Med 309 (1983) 1210-1213
218. Schnapka G., Hofstaedter F., Schwamberger K., and Reissigl H. Gastric stump carcinoma following Billroth II resection for peptic ulcer disease. Comparison with cancer in non-operated stomach. Endoscopy 16 (1984) 171-174
219. Hansson L.E., Nyren O., Hsing A.W., Bergstrom R., Josefsson S., Chow W.H., et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 335 (1996) 242-249
220. Pointner R., Schwab G., Konigsrainer A., Bodner E., and Schmid K.W. Early cancer of the gastric remnant. Gut 29 (1988) 298-301
221. Greene F.L. Early detection of gastric remnant carcinoma. The role of gastroscopic screening. Arch Surg 122 (1987) 300-303
222. Geboes K., Rutgeerts P., Broeckaert L., Vantrappen G., and Desmet V. Histologic appearances of endoscopic gastric mucosal biopsies 10-20 years after partial gastrectomy. Ann Surg 192 (1980) 179-182
223. Marrero J.M., de Caestecker J.S., Corbishley C.M., McCormick C., and Northfield T.C. Gastric DNA content in postgastrectomy patients. Relationship to mucosal dysplasia. Cancer 77 (1996) 19-24
224. Offerhaus G.J., van de Stadt J., Huibregtse K., Tersmette A.C., and Tytgat G.N. The mucosa of the gastric remnant harboring malignancy. Histologic findings in the biopsy specimens of 504 asymptomatic patients 15 to 46 years after partial gastrectomy with emphasis on nonmalignant lesions. Cancer 64 (1989) 698-703
225. Stael von Holstein C., Hammar E., Eriksson S., and Huldt B. Clinical significance of dysplasia in gastric remnant biopsy specimens. Cancer 72 (1993) 1532-1535
226. Greene F.L. Management of gastric remnant carcinoma based on the results of a 15-year endoscopic screening program. Ann Surg 223 (1996) 701-706
227. Sonnenberg A. Endoscopic screening for gastric stump cancer-would it be beneficial?. A hypothetical cohort study. Gastroenterology 87 (1984) 489-495
228. Sasako M., Maruyama K., Kinoshita T., and Okabayashi K. Surgical treatment of carcinoma of the gastric stump. Br J Surg 78 (1991) 822-824
229. Kodera Y., Yamamura Y., Torii A., Uesaka K., Hirai T., Yasui K., et al. Gastric remnant carcinoma after partial gastrectomy for benign and malignant gastric lesions. J Am Coll Surg 182 (1996) 1-6
230. Furukawa H., Iwanaga T., Hiratsuka M., Imaoka S., Ishikawa O., Kabuto T., et al. Gastric remnant cancer as a metachronous multiple lesion. Br J Surg 80 (1993) 54-56
231. Viste A., Eide G.E., Glattre E., and Soreide O. Cancer of the gastric stump: analyses of 819 patients and comparison with other stomach cancer patients. World J Surg 10 (1986) 454-461
232. Ikeguchi M., Kondou A., Shibata S., Yamashiro H., Tsujitani S., Maeta M., et al. Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach. Cancer 73 (1994) 15-21
233. Eckardt V.F., Giessler W., Kanzler G., Remmele W., and Bernhard G. Clinical and morphological characteristics of early gastric cancer. A case-control study. Gastroenterology 98 (1990) 708-714
234. Green P.H., O'Toole K.M., Weinberg L.M., and Goldfarb J.P. Early gastric cancer. Gastroenterology 81 (1981) 247-256
235. Moreaux J., and Bougaran J. Early gastric cancer. A 25-year surgical experience. Ann Surg 217 (1993) 347-355
236. Lawrence M., and Shiu M.H. Early gastric cancer. Twenty-eight-year experience. Ann Surg 213 (1991) 327-334
237. Okuda H., Suzuki S., Suzuki H., Kurokawa K., Kitamura Y., Mitsunaga A., et al. Diagnosis and prognosis of early gastric cancer: the experience in Japan. Trop Gastroenterol 9 (1988) 7-13
238. Gebhardt C., Husemann B., Hermanek P., and Gentsch H.H. Clinical aspects and therapy of early gastric cancer. World J Surg 5 (1981) 721-724
239. Sano T., Katai H., Sasako M., and Maruyama K. The management of early gastric cancer. Surg Oncol 9 (2000) 17-22
240. Kuwayama H., Eastwood G.L., Kohashi E., and Honda T. Endoscopic local injection of early gastric carcinoma with 5-fluorouracil. Dig Dis Sci 29 (1984) 498-501
241. Sakita T., Koyama S., Ishii M., Togo J., Miyamoto J., Nakahara A., et al. Early cancer of the stomach treated successfully with an endoscopic neodymium-YAG laser: report of a case. Am J Gastroenterol 76 (1981) 441-445
242. Kitagawa Y., Fujii H., Mukai M., Kubota T., Otani Y., and Kitajima M. Radio-guided sentinel node detection for gastric cancer. Br J Surg 89 (2002) 604-608
243. Seto Y., Yamaguchi H., Shimoyama S., Shimizu N., Aoki F., and Kaminishi M. Results of local resection with regional lymphadenectomy for early gastric cancer. Am J Surg 182 (2001) 498-501
244. Kitano S., and Shiraishi N. Minimally invasive surgery for gastric tumors. Surg Clin North Am 85 (2005) 151-164 xi
245. Huscher C.G., Mingoli A., Sgarzini G., Sansonetti A., Di Paola M., Recher A., et al. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg 241 (2005) 232-237
246. ReMine W.H. Palliative operations for incurable gastric cancer. World J Surg 3 (1979) 721-729
247. Miner T.J., Jaques D.P., Karpeh M.S., and Brennan M.F. Defining palliative surgery in patients receiving noncurative resections for gastric cancer. J Am Coll Surg 198 (2004) 1013-1021
248. Haugstvedt T., Viste A., Eide G.E., and Soreide O. The survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience. Norwegian Stomach Cancer Trial. World J Surg 13 (1989) 617-621
249. Monson J.R., Donohue J.H., McIlrath D.C., Farnell M.B., and Ilstrup D.M. Total gastrectomy for advanced cancer. A worthwhile palliative procedure. Cancer 68 (1991) 1863-1868
250. Boddie Jr. A.W., McMurtrey M.J., Giacco G.G., and McBride C.M. Palliative total gastrectomy and esophagogastrectomy. A reevaluation. Cancer 51 (1983) 1195-1200
251. Bozzetti F., Bonfanti G., Audisio R.A., Doci R., Dossena G., Gennari L., et al. Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet 164 (1987) 151-154
252. Cosentini E.P., Sautner T., Gnant M., Winkelbauer F., Teleky B., and Jakesz R. Outcomes of surgical, percutaneous endoscopic, and percutaneous radiologic gastrostomies. Arch Surg 133 (1998) 1076-1083
253. Dormann A.J. Endoscopic palliation and nutritional support in advanced gastric cancer. Dig Dis 22 (2004) 351-359
254. Sarela A.I., Miner T.J., Karpeh M.S., Coit D.G., Jaques D.P., and Brennan M.F. Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma. Ann Surg 243 (2006) 189-195
255. Macdonald J.S., Schein P.S., Woolley P.V., Smythe T., Ueno W., Hoth D., et al. 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 93 (1980) 533-536
256. Preusser P., Achterrath W., Wilke H., Lenaz L., Fink U., Heinicke A., et al. Chemotherapy of gastric cancer. Cancer Treat Rev 15 (1988) 257-277
257. Ogawa M. A recent overview of chemotherapy for advanced stomach cancer in Japan. Antibiot Chemother 24 (1978) 149-159
258. Cocconi G., DeLisi V., and Di B.B. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer. Cancer Treat Rep 66 (1982) 1263-1266
259. Cullinan S.A., Moertel C.G., Fleming T.R., Rubin J.R., Krook J.E., Everson L.K., et al. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin. JAMA 253 (1985) 2061-2067
260. Klein H.O. Long-term results with FAMTX (5-fluorouracil, adriamycin, methotrexate) in advanced gastric cancer. Anticancer Res 9 (1989) 1025-1026
261. Wils J.A., Klein H.O., Wagener D.J., Bleiberg H., Reis H., Korsten F., et al. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin-a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. J Clin Oncol 9 (1991) 827-831
262. Kelsen D.P., Buckner J., Einzig A., Magill G., Heelan R., and Vinciguerra V. Phase II trial of cisplatin and etoposide in adenocarcinomas of the upper gastrointestinal tract. Cancer Treat Rep 71 (1987) 329-330
263. Preusser P., Wilke H., Achterrath W., Fink U., Lenaz L., Heinicke A., et al. Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol 7 (1989) 1310-1317
264. Wilke H., Preusser P., Fink U., Achterrath W., Meyer H.J., Stahl M., et al. New developments in the treatment of gastric carcinoma. Semin Oncol 17 1 Suppl 2 (1990) 61-70
265. Vanhoefer U., Rougier P., Wilke H., Ducreux M.P., Lacave A.J., Van C.E., et al. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 18 (2000) 2648-2657
266. Cunningham D., Cahn A., and Menzies-Gow N. Cisplatin, epirubicin and 5-fluorouracil (CEF) has significant activity in advance gastric cancer. Proc ASCO 9 (1990) 123
267. Waters J.S., Norman A., Cunningham D., Scarffe J.H., Webb A., Harper P., et al. Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer 80 1-2 (1999) 269-272
268. Moiseyenko V.M., Ajani J.A., Tjulandin A., Majlis M., Consela C., and Boni A. Final results of a randomized controlled phase III trial (TAX 325) comparing docetaxel (T) combined with cisplatin (C) and 5-flurouracil (F) to CF in patients with metastatic gastric adenocarcinoma. Proc ASCO 43 (2005) 308
269. Wagner A.D., Grothe W., Behl S., Kleber G., Grothey A., Haerting J., et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev 2 (2005) CD004064
270. Boku N., Chin K., Hosokawa K., Ohtsu A., Tajiri H., Yoshida S., et al. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum. Clin Cancer Res 4 (1998) 1469-1474
271. The Gastrointestinal Tumor Study Group. The concept of locally advanced gastric cancer. Effect of treatment on outcome. Cancer 66 (1990) 2324-2330
272. Higgins G.A., Amadeo J.H., Smith D.E., Humphrey E.W., and Keehn R.J. Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A Veterans Administration Surgical Oncology, Group report. Cancer 52 (1983) 1105-1112
273. Lise M., Nitti D., Marchet A., Sahmoud T., Buyse M., Duez N., et al. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. J Clin Oncol 13 (1995) 2757-2763
274. Macdonald J.S., Fleming T.R., Peterson R.F., Berenberg J.L., McClure S., Chapman R.A., et al. Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study. Ann Surg Oncol 2 (1995) 488-494
275. Imanaga H., and Nakazato H. Results of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence. World J Surg 2 (1977) 213-221
276. Nakajima T., Takahashi T., Takagi K., Kuno K., and Kajitani T. Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer. J Clin Oncol 2 (1984) 1366-1371
277. Hermans J., Bonenkamp J.J., Boon M.C., Bunt A.M., Ohyama S., Sasako M., et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 11 (1993) 1441-1447
278. Earle C.C., and Maroun J.A. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 35 (1999) 1059-1064
279. Moertel C.G., Childs D.S., O'Fallon J.R., Holbrook M.A., Schutt A.J., and Reitemeier R.J. Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. J Clin Oncol 2 (1984) 1249-1254
280. Herskovic A., Martz K., al-Sarraf M., Leichman L., Brindle J., Vaitkevicius V., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326 (1992) 1593-1598
281. Macdonald J.S., Smalley S.R., Benedetti J., Hundahl S.A., Estes N.C., Stemmermann G.N., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
282. Allum N., Cunningham D., Weeden S., and UK NCRI Upper GI Clinical Studies Group. Peri-operative chemotherapy in operable gastric and lower esophageal cancer: randomised controlled trial (the Magic Trial). Proc ASCO 22 (2005) 249